We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Hikma Pharmaceuticals Plc | HIK | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -48.00 | -2.05% | 2,292.00 | 16:35:28 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 2,342.00 | 2,284.00 | 2,350.00 | 2,292.00 | 2,340.00 |
| Industry Sector |
|---|
| PHARMACEUTICALS & BIOTECHNOLOGY |
| Announcement Date | Type | Currency | Dividend Amount | Ex Date | Record Date | Payment Date |
|---|---|---|---|---|---|---|
| 08/08/2024 | Interim | USD | 0.32 | 15/08/2024 | 16/08/2024 | 20/09/2024 |
| 22/02/2024 | Final | USD | 0.47 | 21/03/2024 | 22/03/2024 | 03/05/2024 |
| 03/08/2023 | Interim | USD | 0.25 | 10/08/2023 | 11/08/2023 | 15/09/2023 |
| 23/02/2023 | Final | USD | 0.37 | 23/03/2023 | 24/03/2023 | 05/05/2023 |
| 04/08/2022 | Interim | USD | 0.19 | 18/08/2022 | 19/08/2022 | 20/09/2022 |
| 24/02/2022 | Final | GBP | 0.276476 | 17/03/2022 | 18/03/2022 | 28/04/2022 |
| 06/08/2021 | Interim | USD | 0.18 | 19/08/2021 | 20/08/2021 | 20/09/2021 |
| 25/02/2021 | Final | USD | 0.34 | 18/03/2021 | 19/03/2021 | 26/04/2021 |
| 07/08/2020 | Interim | USD | 0.16 | 20/08/2020 | 21/08/2020 | 21/09/2020 |
| 27/02/2020 | Final | GBP | 0.242169 | 19/03/2020 | 20/03/2020 | 07/05/2020 |
| Top Posts |
|---|
Posted at 07/11/2024 11:55 by martinmc123 4*Hikma issued an encouraging trading update this morning. The Group is performing well and management continue to expect Group revenue to grow in the range of 6% to 8% and for core operating profit to be in the range of $700 million to $730 million in 2024, in line with previously upgraded guidance. All 3 segments - Injectables, Branded and Generics – are performing well...from WealthOracle wealthoracle.co.uk/d |
Posted at 01/11/2024 08:51 by dartboard1 Not so much relevant to HIK tho as they only sell generics in North America I believe, non to EU market. Unless anyone knows otherwise. |
Posted at 28/8/2024 15:39 by dartboard1 Cheers HH... I see ppl call out these trades and most of the time it's admin from the brokers rather than indicating anything coming ... hikma is a slow moving beast, it's slowly going about its business. Growing at low digits in revenue but divi is growing at a larger percentage which is key to long term holders... |
Posted at 22/2/2024 07:06 by robertball Dividend hike is chunky |
Posted at 13/1/2024 21:31 by hopeful holder So far, HIK has proven to be better even over this short period. |
Posted at 02/3/2023 17:11 by waldron LOOKING TOPPYNOT IMPRESSED WITH DIVI Having said that if results good, might move up 20pc if EV anything to go by |
Posted at 30/9/2022 09:32 by cumnor Bought in here at £13 avg. Now the diversity nonsense is out of the way these guys (and gals I suppose) need to up the ante on their dividend payments if they wish to recover the share price..... |
Posted at 15/9/2022 11:01 by swinsco Jeffries have just cut Hik price target to 2020 from 2200 and keep it a buy rating. Broker nonsense! |
Posted at 01/9/2022 10:56 by mjneish Good to see HIK outperforming the wider market at the moment. FTSE down 1.5% at the moment, and HIK down only 1%. :) |
Posted at 18/8/2022 19:32 by cumnor Punters and IIs are tiring of indebted companies like Hikma which paid divis of 2% for past couple of years, promised the earth and fail to deliver, as recent results show. Meanwhile directors pay themselves huge salaries and bonuses but expect investors to pay dear for the measly dividend. This could have been more generous and the recent falls (not just here) in poor payers share prices reflect a change in attitude to greedy directors.Needs to see a divi of 5% plus before I'd touch this. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
